REG - Ergomed plc - Director's Dealing
RNS Number : 5199SErgomed plc07 November 2019Ergomed Plc
("Ergomed" or the "Company")
Director's Dealing
Ergomed, a company focused on providing specialised services to the pharmaceutical industry, announces that on 6 November 2019, Dr Miroslav Reljanovic, founder and Executive Chairman of the Company, transferred 176,470 ordinary shares of 1 pence each in the Company ("Share(s)") to a former employee of the Company (the "Transfer"). The Transfer took place following an exercise of options over Ergomed shares owned by Dr Miroslav Reljanovic which had been granted on 20 July 2015 at an exercise price of 1 pence per Share.
Following the Transfer, Dr Miroslav Reljanovic's holding has reduced to 10,879,297 Shares (representing 23.0 per cent. of the Company's issued share capital).
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Dr Miroslav Reljanovic
2
Reason for the notification
a)
Position/status
Founder and Executive Chairman
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Ergomed Plc
b)
Legal Entity Identifier
213800BVS8I9VMC1AP84
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1 pence each
GB00BN7ZCY67
b)
Nature of the transaction
Transfer of Shares
c)
Currency
GBP
d)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.01
176,470
e)
Aggregated information
- Aggregated volume
- Price
- Aggregated total
Volume: 176,470 ordinary shares of 1 pence each, exercise price of 1 pence per share
f)
Date of the transaction
6 November 2019
g)
Place of the transaction
Outside of a trading venue
Enquiries:
Ergomed plc
Tel: +44 (0) 1483 503205
Miroslav Reljanović (Executive Chairman)
Richard Barfield (Chief Financial Officer)
Numis Securities Limited
Tel: +44 (0) 20 7260 1000
Freddie Barnfield / Huw Jeremy (Nominated Adviser)
James Black (Broker)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHBFBITMBMMBJL
Recent news on Ergomed
See all newsREG - Ergomed plc - Cancellation of admission to trading of shares
AnnouncementREG - AIM Ergomed plc - Cancellation - Ergomed plc
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Ergomed plc
AnnouncementREG - BlackRock Group Ergomed plc - Form 8.3 - Ergomed plc
Announcement